Can an app or a book ease IBD disability? large trial tests free Self-Help options
NCT ID NCT06646757
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed trial tested whether four free self-help resources—a symptom-tracking app, a cognitive behavioral therapy workbook, a helpline, and a peer mentor—can reduce disability in people with moderate-to-severe Crohn's disease or ulcerative colitis. Over 800 adults participated online for 12 weeks. The goal was to see if these tools boost confidence in managing the disease and lessen daily limitations.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- behavioral interventions (self-help app, CBT workbook, helpline, peer mentor)
- What this could lead to
- If effective, these free tools could help people with IBD feel more in control and reduce daily disability without medication.
- What could go wrong
- This is a completed study, but results are not yet published. The interventions are behavioral, so benefits may vary widely between individuals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
803 people
The number who actually took part.
- Started
-
Aug 2024
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Adults (age ≥ 18 years) with IBD and moderate-to-severe IBD-related (IBD) Disability Index score \> 35 26,27) 2. Able to consent, complete surveys, and participate in focus groups in English. Exclusion Criteria: 1. No/low disability (IBD-DI \< 35) on the baseline survey 2. Inability or unwillingness to participate in the interventions 3. Inability to download apps from the Apple AppStore or Google Play store (necessary to engage with the smartapp intervention) 4. Limited English proficiency (necessary because some interventions are currently only offered in English)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Crohn disease (CD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Triple-Pronged attack on gut inflammation put to the test
- Two biologics go head to head in ulcerative colitis
- Can tissue clues predict which Crohn's patients relapse after surgery?
- New drug ATTO-1091 put to the test for safety in ulcerative colitis
- Antiparasitic drug tested as new weapon against ulcerative colitis
- Could your Donor's gut bacteria decide whether a stool transplant works?